Brain-derived endothelial cells are neuroprotective in a chronic cerebral hypoperfusion mouse model

Yuichi Matsui,Fumitaka Muramatsu,Hajime Nakamura,Yoshimi Noda,Kinnosuke Matsumoto,Haruhiko Kishima,Nobuyuki Takakura

DOI: https://doi.org/10.1038/s42003-024-06030-x

IF: 6.548

2024-03-20

Communications Biology

Abstract:Whether organ-specific regeneration is induced by organ-specific endothelial cells (ECs) remains unelucidated. The formation of white matter lesions due to chronic cerebral hypoperfusion causes cognitive decline, depression, motor dysfunction, and even acute ischemic stroke. Vascular ECs are an important target for treating chronic cerebral hypoperfusion. Brain-derived ECs transplanted into a mouse chronic cerebral hypoperfusion model showed excellent angiogenic potential. They were also associated with reducing both white matter lesions and brain dysfunction possibly due to the high expression of neuroprotective humoral factors. The in vitro coculture of brain cells with ECs from several diverse organs suggested the function of brain-derived endothelium is affected within a brain environment due to netrin-1 and Unc 5B systems. We found brain CD157-positive ECs were more proliferative and beneficial in a mouse model of chronic cerebral hypoperfusion than CD157-negative ECs upon inoculation. We propose novel methods to improve the symptoms of chronic cerebral hypoperfusion using CD157-positive ECs.

biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is white matter damage caused by chronic cerebral hypoperfusion and the resulting problems such as cognitive function decline, depression, and movement disorders. Specifically, the authors explored the transplantation effects of vascular endothelial cells (ECs) from different sources in a mouse model of chronic cerebral hypoperfusion, especially whether brain - derived endothelial cells (BDECs) can more effectively promote angiogenesis, reduce white matter lesions, and improve brain functions (such as memory). In addition, the study also explored the potential of CD157 - positive vascular endothelial cells in the treatment of chronic cerebral hypoperfusion.

The main findings of the paper include:
1. Brain - derived endothelial cells showed stronger proliferation ability and better angiogenesis ability in a mouse model of chronic cerebral hypoperfusion, which could significantly reduce white matter lesions and improve cognitive function.
2. After transplantation, brain - derived endothelial cells can form specific cerebral blood vessels with blood - brain barrier (BBB) function, while vascular endothelial cells from other organs cannot fully perform this function.
3. The study found that brain - derived endothelial cells highly express neurotrophic factors (such as BDNF), which may be one of the reasons for their neuroprotective effects.
4. Further research shows that brain - derived endothelial cells express more Unc 5B receptors, and Unc 5B interacts with netrin - 1, which may play a key role in the proliferation and specific angiogenesis of brain - derived endothelial cells.
5. Finally, the research team tested the effects of CD157 - positive vascular endothelial cells and found that these cells have higher proliferation ability and better treatment effects in the chronic cerebral hypoperfusion model.

In conclusion, this study provides new ideas for the treatment of chronic cerebral hypoperfusion, especially by transplanting specific types of vascular endothelial cells to improve the symptoms of patients.